HIV Diagnostics Market Analysis & Technological Innovation by Top Key Players Roche, Abbott, Siemens, Qiagen, Sysmex and Hologic & More

Market Study Report adds global HIV Diagnostics market report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years.

HIV Diagnostics Market size is estimated to reach USD 4.9 billion by 2023; as per a new research report. Growing prevalence, and increasing government and corporate initiatives for HIV infection awareness should propel global HIV diagnostics market size.

Rising HIV/AIDS cost burden on healthcare systems has led to establishment of various associations and campaigns working towards the awareness regarding early diagnosis of disease. Global HIV diagnostics market size was USD 2.4 billion in 2015, with 9.5% CAGR increase during the forecast period.

Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/467735/

Various public awareness and education campaigns have been developed by Federal agencies. For instance, a campaign sponsored by Centers for Disease Control and Prevention (CDC) emphasizes the importance of HIV testing for people aged between 18 to 64. Another campaign driven by U.S. Department of Health and Human Services? Office on Women?s Health provides teen girls with information regarding HIV and its prevention.

Introduction of technologically advanced products such as point of care rapid diagnostic tests, and portable cell counters that require minimum technical skills for its functioning increasing the speed of diagnosis. Other technological advancements include fluorescence microscopy devices, and flow cytometric instruments used for these tests improving the accuracy for the same.

Strong requirement for affordable, readily available, high quality and efficient tests will also drive HIV diagnostics industry revenue. Usage rate for custom based, rapid and feasible PoC tests that can be done by non-healthcare providers has been steadily growing, which has led to an increase in demand for antibody tests such as HIV-1 screening, HIV-1 confirmatory, HIV-2 & Group O making it the largest product segment in the overall market.

Significant supply lag of diagnostic facilities across India, Malaysia, Indonesia, Brazil, China, and South Korea offers a strong platform for industry participants to expand regional business. APAC, with growth hinged on China and India HIV diagnostics market, could see reach USD 1.05 billion in revenue by 2023. LATAM was predominantly driven by Brazil HIV diagnostics market size, exceeding USD 250 million by 2023.

Key insights from the report include:
Global HIV diagnostics market size is anticipated to reach USD 4.9 billion by 2023 from 2.4 billion in 2015, growing at an estimated CAGR of 9.5% from 2016 to 2023.

U.S. HIV diagnostics market share was the largest in North America, grabbing revenue of more than 75% in 2015. Regulatory support to prevent rising number of HIV/AIDS cases, and introduction of portable, convenient to use diagnostic tests is set to drive regional growth.

Antibody tests segment dominated the global HIV diagnostics market share in 2015, at more than USD 750 million in revenue, while the antibody test market was predominantly driven by HIV-1 screening tests market.

Germany was the revenue puller for Europe HIV diagnostics market, slated to showcase bringing in over 20% revenue in 2015, while UK is likely to witness relatively higher growth rate.

Capital intensive nature of the industry, existing established players, and requirement of highly qualified personnel pose as challenges for new players to enter the market.

In APAC, China HIV diagnostics market is the fastest growing region, showcasing 10.9% CAGR during the forecast period, followed by Japan.
Roche, Abbott, Siemens, Qiagen, Sysmex and Hologic are some key companies for this industry.

Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/467735/

Selected points from Table of Contents of this report:

Chapter 1. Methodology and Scope
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical modeling and forecast
1.1.3. Industry insights and validation
1.2. Data Sources

Chapter 2. Executive Summary
2.1. HIV diagnostics industry 360 degree synopsis, 2012 - 2023
2.1.1. Business trends
2.1.2. Regional trends
2.1.3. Application trends

Chapter 3. HIV Diagnostics Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2012 - 2023
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Favorably regulatory landscape
3.3.1.2. PoC HIV diagnostics development
3.3.1.3. Increasing HIV/AIDS prevalence
3.3.2. Industry pitfalls & challenges
3.3.2.1. Low degree of penetration in undeveloped regional markets
3.4. Growth potential analysis
3.5. Porter's analysis
3.6. PESTEL analysis

For More Details about this report: https://www.marketstudyreport.com/reports/hiv-diagnostics-market

About Us:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Us:
Market Study Report
4 North Main Street,
Selbyville, Delaware 19975
USA
Phone: 1-302-273-0910
US Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com
Web site: https://www.marketstudyreport.com
Blog: https://www.marketstudyreport.com/blog/

This release was published on openPR.